8-K
Current Report
Acrivon Therapeutics, Inc. Filed Acc 0000950170-24-075760
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading acrv-20240620.htm…